EDGAR Filing Documents for 0001019687-13-001578

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001019687-13-001578

Filing Date

2013-05-01

Accepted

2013-05-01 19:42:58

Documents

Period of Report

2013-04-30

Document Format Files

Seq	Description	Document	Type	Size
1	OWNERSHIP DOCUMENT	king_f4-043013.html	4
1	OWNERSHIP DOCUMENT	king_f4-043013.xml	4	3238
	Complete submission text file	0001019687-13-001578.txt		4651

Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780

Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000

PEREGRINE PHARMACEUTICALS INC (Issuer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations

Mailing Address

Business Address

Type: 4 | Act: 34 | File No.: 001-32839 | Film No.: 13804989